Glioma-on-a-Chip Models
Glioma, as an aggressive type of cancer, accounts for virtually 80% of malignant brain tumors. Despite advances in therapeutic approaches, the long-term survival of glioma patients is poor (it is usually fatal within 12–14 months). Glioma-on-chip platforms, with continuous perfusion, mimic in vivo m...
Main Authors: | Merve Ustun, Sajjad Rahmani Dabbagh, Irem Sultan Ilci, Tugba Bagci-Onder, Savas Tasoglu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Micromachines |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-666X/12/5/490 |
Similar Items
-
Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing
by: Leslie Donoghue, et al.
Published: (2021-01-01) -
The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors
by: Grissel Trujillo-de Santiago, et al.
Published: (2019-09-01) -
A Decade of Organs-on-a-Chip Emulating Human Physiology at the Microscale: A Critical Status Report on Progress in Toxicology and Pharmacology
by: Mario Rothbauer, et al.
Published: (2021-04-01) -
Microfluidic Organ/Body-on-a-Chip Devices at the Convergence of Biology and Microengineering
by: Ana Rubina Perestrelo, et al.
Published: (2015-12-01) -
A microfluidic model of human brain (μHuB) for assessment of blood brain barrier
by: Tyler D. Brown, et al.
Published: (2019-05-01)